You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Angiogenic Capability of Peripheral Blood Mononuclear Cells in Psoriasis

Slawomir Majewski, MD; Marek Kaminski, MD; Stefania Jablonska, MD; Andrzej Szmurlo, MD; Maria Pawinska, MD

Arch Dermatol. 1985;121(8):1018-1021.


Abstract

• The angiogenic capability of peripheral blood mononuclear cells (MNCs) from patients with psoriasis was tested by lymphocyte-induced angiogenesis assay. The study was performed in 36 patients with psoriasis vulgaris, six with generalized pustular psoriasis of the von Zumbusch type, and five with palmo-plantar pustular psoriasis. When patients with psoriasis vulgaris were considered as a whole, no significant differences in the angiogenic capability of their MNCs could be detected, as compared with controls. However, when cases of psoriasis were classified into various types, the differences in angiogenic capability of MNCs became evident. This capability was found to be markedly increased in the active form of psoriasis vulgaris and decreased in the stationary stage of the disease. It was increased in palmo-plantar pustular psoriasis but markedly decreased in generalized pustular psoriasis of the von Zumbusch type.

(Arch Dermatol 1985;121:1018-1021)



Author Affiliations

From the Departments of Dermatology (Drs Majewski, Kaminski, Jablonska, and Powinska) and Histology (Drs Majewski, Kaminski, and Szmurlo), Warsaw School of Medicine.


Footnotes

Accepted for publication Dec 11, 1984.

Reprint requests to Department of Dermatology, Warsaw School of Medicine, 02-008 Warszawa, Koszykowa 82A, Poland (Dr Majewski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor beta 1
Takashima and Klagsbrun
J. Biol. Chem. 1996;271:24901-24906.
ABSTRACT | FULL TEXT  

Serum Samples From Patients With Active Psoriasis Enhance Lymphocyte-Induced Angiogenesis and Modulate Endothelial Cell Proliferation
Majewski et al.
Arch Dermatol 1987;123:221-225.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.